Research Center in Infectious Diseases of the CHU of Québec and Laval University, Québec City, Québec, Canada.
Quebec Heart and Lung Institute, Department of Anatomopathology and Cytology, Laval University, Québec City, Québec, Canada.
Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4.
The mouse is the most widely used animal model for influenza virus research. However, the susceptibility of mice to seasonal influenza virus depends on the strain of mouse and on the strain of the influenza virus. Seasonal A/H3N2 influenza viruses do not replicate well in mice and therefore they need to be adapted to this animal model. In this study, we generated a mouse-adapted A/H3N2 virus (A/Switzerland/9715293/2013 [MA-H3N2]) by serial passaging in mouse lungs that exhibited greater virulence compared to the wild-type virus (P0-H3N2). Seven mutations were found in the genome of MA-H3N2: PA(K615E), NP(G384R), NA(G320E) and HA(N122D, N144E, N246K, and A304T). Using reverse genetics, two synergistically acting genes were found as determinants of the pathogenicity in mice. First, the HA substitutions were shown to enhanced viral replication in vitro and, second, the PA-K615E substitution increased polymerase activity, although did not alter virus replication in vitro or in mice. Notably, single mutations had only limited effects on virulence in vitro. In conclusion, a co-contribution of HA and PA mutations resulted in a lethal mouse model of seasonal A/H3N2 virus. Such adapted virus is an excellent tool for evaluation of novel drugs or vaccines and for study of influenza pathogenesis.
小鼠是流感病毒研究中最广泛使用的动物模型。然而,小鼠对季节性流感病毒的易感性取决于小鼠的品系和流感病毒的株系。季节性 A/H3N2 流感病毒在小鼠体内不能很好地复制,因此需要适应这种动物模型。在本研究中,我们通过在小鼠肺部的连续传代生成了一种适应小鼠的 A/H3N2 病毒(A/Switzerland/9715293/2013 [MA-H3N2]),与野生型病毒(P0-H3N2)相比,该病毒的毒力更强。在 MA-H3N2 的基因组中发现了 7 个突变:PA(K615E)、NP(G384R)、NA(G320E)和 HA(N122D、N144E、N246K 和 A304T)。通过反向遗传学,发现了两个协同作用的基因是导致小鼠致病性的决定因素。首先,HA 取代被证明增强了病毒在体外的复制,其次,PA-K615E 取代增加了聚合酶活性,尽管它并没有改变病毒在体外或在小鼠体内的复制。值得注意的是,单个突变对体外的毒力只有有限的影响。总之,HA 和 PA 突变的共同作用导致了季节性 A/H3N2 病毒的致死性小鼠模型。这种适应病毒是评估新型药物或疫苗以及研究流感发病机制的极好工具。